A 74-Year-Old-Man with Metastatic Prostate Cancer - Episode 6

Selecting Between Treatment With Cabazitaxel or Radiotherapy for Patients with mCRPC

Dr Shore details how he approaches treatment selection between cabazitaxel and radiotherapy for patients with mCRPC.